Anebulo Pharmaceuticals, Inc. out of Austin, Tex. believes it can help better equip emergency room (ER) doctors to more effectively address the increasing number of drug intoxication cases, including those related to cannabis.
Story continues below
This advertisement has not loaded yet, but your article continues below.
Focused on therapeutic solutions for substance use disorders, the clinical stage biotech company is set on developing an antidote for cannabis intoxication.
A company-sponsored survey of 27 ER physicians in the U.S. indicated a “strong need for a cannabinoid antagonist to treat cannabis intoxication,” notes information posted on its website. In fact, on a scale of 0 to 10, the physicians responded that the need for such as treatment scored about 7.5.
Read full article on The Growth Op
